AllianceBernstein
LEGN icon

AllianceBernstein’s Legend Biotech LEGN Stock Holding History

AllianceBernstein’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,517,067
Closed -$33M – 3269
2025
Q4 		$33M Sell
1,517,067
-115,900
-7% -$3.32M 0.01% 754
2025
Q3 		$53.3M Buy
1,632,967
+72,371
+5% +$2.67M 0.02% 605
2025
Q2 		$55.4M Buy
1,560,596
+52,344
+3% +$1.7M 0.02% 576
2025
Q1 		$51.2M Buy
1,508,252
+32,101
+2% +$1.15M 0.02% 581
2024
Q4 		$48M Buy
1,476,151
+164,418
+13% +$6.81M 0.02% 601
2024
Q3 		$63.9M Buy
1,311,733
+223,884
+21% +$11.9M 0.02% 544
2024
Q2 		$48.2M Sell
1,087,849
-25,309
-2% -$1.17M 0.02% 602
2024
Q1 		$62.4M Sell
1,113,158
-72,799
-6% -$4.39M 0.02% 539
2023
Q4 		$71.4M Buy
1,185,957
+84,076
+8% +$5.33M 0.03% 502
2023
Q3 		$74M Sell
1,101,881
-339,011
-24% -$23.5M 0.03% 464
2023
Q2 		$99.5M Sell
1,440,892
-137,055
-9% -$8.96M 0.04% 392
2023
Q1 		$76.1M Buy
1,577,947
+286,249
+22% +$14M 0.03% 459
2022
Q4 		$64.5M Sell
1,291,698
-244,573
-16% -$11.8M 0.03% 503
2022
Q3 		$62.7M Buy
1,536,271
+70,651
+5% +$3.32M 0.03% 480
2022
Q2 		$80.6M Sell
1,465,620
-613,155
-29% -$25.9M 0.04% 429
2022
Q1 		$75.5M Buy
2,078,775
+51,176
+3% +$2.02M 0.03% 489
2021
Q4 		$94.5M Buy
2,027,599
+29,449
+1% +$1.49M 0.03% 458
2021
Q3 		$101M Buy
1,998,150
+101,167
+5% +$4.21M 0.04% 422
2021
Q2 		$77.9M Sell
1,896,983
-223,308
-11% -$7.59M 0.03% 505
2021
Q1 		$61.5M Buy
2,120,291
+890,832
+72% +$24.3M 0.03% 545
2020
Q4 		$34.6M Sell
1,229,459
-153,980
-11% -$4.43M 0.02% 685
2020
Q3 		$42.7M Buy
1,383,439
+311,039
+29% +$10.5M 0.02% 580
2020
Q2 		$45.6M Buy
+1,072,400
New +$41.9M 0.03% 532

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AllianceBernstein's LEGN Position: Q1 2026 in Review

AllianceBernstein sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 1,517,067 shares — an estimated $33M sold.

AllianceBernstein first reported a position in LEGN in Q2 2020 and held it in 23 quarters. The position peaked at $101M in Q3 2021. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • AllianceBernstein reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • AllianceBernstein sold 1,517,067 Legend Biotech shares in Q1 2026, an estimated $33M.
  • AllianceBernstein first reported a position in Legend Biotech in Q2 2020 and held it in 23 quarters.
  • AllianceBernstein's Legend Biotech position peaked at $101M in Q3 2021.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.